JMJD6 and cancer: Despite ample evidence supporting the pivotal role of JMJD6 in the treatment and prognosis of patients with cancer [22,25] and its relevance in managing ischemic cardiovascular diseases [26], a noticeable lack of research is observed regarding the autoantibodies against JMJD6.